Treating Acute Leukemias in Canada and Latin America
Emerging and Practical Concepts and Controversies in Leukemias
Overview
In recent years, progress in the understanding of acute leukemias has led to novel therapies that are rapidly changing treatment paradigms. Aptitude Health developed the Global Leukemia Academy to help physicians who treat acute leukemias bridge the gap between innovation and implementation for patient care.
Date and Location
April 23–24, 2021, Virtual Meeting
Meeting Content
View the slides and watch the video of Day 1
ALL Plenary Session
Faculty
Elias Jabbour, MD
MD Anderson Cancer Center, USA
Franco Locatelli, MD, PhD
University of Rome
IRCCS Ospedale Pediatrico Bambino Gesù, Italy
Lia Gore, MD
University of Colorado,
Anschutz Medical Campus, USA
Roberta Demichelis, MD
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico
José Maria Ribera, MD
Catalan Institute of Oncology, University Hospital Germans Trias i Pujol, Spain
Andre Schuh, MD
Princess Margaret Cancer Centre, Canada
Naval Daver, MD
MD Anderson Cancer Center (MDACC), Houston, TX
|
Agenda |
This 2-day interactive virtual meeting with global experts will focus on the management of acute leukemias in adult, young adult, and pediatric patients in various countries within the Latin America and Canadian regions. Day 1: Follow presentations, interact in panel discussions, and debate about novel approved therapies, evolving treatment paradigms, and other hot topics, including patient management during the COVID-19 pandemic. Day 2: Join the pediatric or adult breakout session to learn about treatment strategies for newly diagnosed and relapsed leukemia patients and attend the patient case-based panel discussion about toxicity management. |
Day 1 – PLENARY SESSIONS Friday, April 23, 2021
Chair: Elias Jabbour, MD
16.00 – 20.00 CDT/GMT-5 (Central Daylight/Mexico City/Bogota Time)
17.00 – 21.00 EDT (Eastern Daylight Time)
18.00 – 22.00 BRT/GMT-3 (Brasilia/Buenos Aires Time)
| Rio Time (UTC-3) | Topic | Presenter |
| 18.00 – 18.10 | Welcome and meeting overview; introduction to the voting system | Elias Jabbour |
| 18.10 – 18.35 | Recent developments in ALL | Elias Jabbour |
| 18.35 – 19.00 | Review of prognostic value of MRD in ALL | José Maria Ribera |
| 19.00 – 19.15 | Genetic variants in ALL – Ph+ and Ph-like | Andre Schuh |
| 19.15 – 19.30 | AYA ALL patients – what is the current treatment approach for this diverse patient population? | Lia Gore |
| 19.30 – 19.45 | Break | |
| 19.45 – 20.00 | Bispecifics as post-reinduction therapy improve survival in high-risk first-relapse AYA B-ALL | Franco Locatelli |
| 20.00 – 20.30 | Therapeutic approaches in older AML and high-risk AML | Naval Daver |
| 20.30 – 21.00 | Debate on sequencing CD19-targeted approaches • Monoclonal antibodies and bispecifics first (10 min) • CAR T first (10 min) • Discussion and voting (10 min) |
Moderator: Andre Shuh Elias Jabbour |
| 21.00 – 21.50 | Leukemia board discussion • Cases – important details for consideration throughout LATAM • Regional challenges • Treatment theory and practical approaches • Discussion and polling (20 min) |
All faculty, Moderator: Elias Jabbour |
| 21.50 – 22.00 | Session close | Elias Jabbour |
Day 2 – BREAKOUT: Saturday, April 24, 2021
Part 1: Adult ALL Patients
Part 2: Adult AML Patients
Chair: Elias Jabbour, MD
Co-chair: Naval Daver, MD
8.00 – 11.30 CDT/GMT-5 (Central Daylight/Mexico City/Bogota Time)
9.00 – 12.30 EDT (Eastern Daylight Time)
10.00 – 13.30 BRT/GMT-3 (Brasilia/Buenos Aires Time)
| Rio Time (UTC-3) | Topic | Presenter |
| 10.00 – 10.15 | Session open • Educational ARS questions for the audience |
Elias Jabbour |
| 10.15 – 10.35 | Optimizing first-line therapy in adult and older ALL – integration of immunotherapy into frontline regimens • Presentation (15 min) • Q&A (5 min) |
Elias Jabbour |
| 10.35 – 10.55 | Current treatment options for relapsed ALL in adult and elderly patients (including COVID-19 and vaccination strategy) • Presentation (15 min) • Q&A (5 min) |
José Maria Ribera |
| 10.55 – 11.45 | Case-based panel discussion: Management of long- and short-term toxicities and treatment selection in adult and elderly patients • Panelists: Elias Jabbour, José Maria Ribera, Andre Schuh, Local Experts |
Roberta Demichelis Wellington Fernandes |
| 11.45 – 12.00 | BREAK | |
| 12.00 – 12.20 | Personalized induction and maintenance approaches for AML • Presentation (15 min) • Q&A (5 min) |
Naval Daver |
| 12.20 – 12.40 | Optimizing management of relapsed/refractory AML • Presentation (15 min) • Q&A (5 min) |
Expert Speaker |
| 12.40 – 13.15 | Case-based panel discussion or questions to the panel on regional challenges in AML care | All experts |
| 13.15 – 13.30 | Session close • Educational ARS questions for the audience |
Elias Jabbour |
Day 2 – BREAKOUT: PEDIATRIC ALL PATIENTS Saturday, April 24, 2021
Chair: Franco Locatelli, MD, PhD
8.00 – 10.30 CDT/GMT-5 (Central Daylight/Mexico City/Bogota Time)
9.00 – 11.30 EDT (Eastern Daylight Time)
10.00 – 12.30 BRT/GMT-3 (Brasilia/Buenos Aires Time)
| Rio Time (UTC-3) | Topic | Presenter |
| 10.00 – 10.15 | Session open • Educational ARS questions for the audience |
Franco Locatelli |
| 10.15 – 10.35 | First-line treatment of pediatric ALL • Presentation (15 min) • Q&A (5 min) |
Lia Gore |
| 10.35 – 10.55 | Current treatment options for relapsed ALL in children, including HSCT; COVID-19 considerations and vaccinations • Presentation (15 min) • Q&A (5 min) |
Franco Locatelli |
| 10.55 – 11.15 | Bispecifics for pediatric ALL • Presentation (15 min) • Q&A (5 min) |
Lia Gore |
| 11.15 – 11.45 | Case-based panel discussion: Management of long-and short-term toxicities and treatment selection in pediatric patients • Panelists: María Sara Felice (ARG), Oscar Gonzáles Ramella (MEX), Adriana Seber (BRA), Carlos Andres Portilla (COL) |
Luisina Perruzo Local case presenterAll faculty |
| 11.45 – 12.30 | Interactive Q&A and session close • Educational ARS questions for the audience |
Franco Locatelli |
